Signal Analysis for Neurocritical Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03362346 |
|
Recruitment Status :
Completed
First Posted : December 5, 2017
Last Update Posted : June 6, 2018
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Brain Injuries, Acute | Device: intracranial pressure monitoring |
| Study Type : | Observational |
| Actual Enrollment : | 156 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Analysis of Physiological Signals From Neurocritical Patients in Intensive Care Units Using Wavelet Transform and Deep Learning |
| Actual Study Start Date : | December 18, 2017 |
| Actual Primary Completion Date : | May 24, 2018 |
| Actual Study Completion Date : | May 31, 2018 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Neurocritical patients
Patients with brain injury from trauma, ischemic stroke, hemorrhage stroke (intracerebral hemorrhage, subarachnoid hemorrhage), brain tumor with increased intracranial pressure, brain infection, hydrocephalus, among others.
|
Device: intracranial pressure monitoring
The patients may have either intracranial pressure (ICP) monitor insertion or external ventricular drainage that can be used as ICP monitor.
Other Name: physiological monitoring |
- Neurological status [ Time Frame: Discharge out of the intensive care unit, averaged 2 weeks ]Glasgow coma scale/Mortality
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age equal to or older than 20 years
- Neurocritical patients admitted to intensive care unit (ICU), including but not limited to traumatic brain injury, hemorrhagic stroke, ischemic stroke, brain infection, brain tumor and acute hydrocephalus.
- Patients who have undergone cranial surgery and had intracranial pressure monitor inserted or external ventricular drainage. The central monitor of ICU is able to collect the data continuously
Exclusion Criteria:
- Age younger than 20 years.
- Continuous monitoring of intracranial pressure is not feasible.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03362346
| Taiwan | |
| Far Eastern Memorial Hospital | |
| New Taipei City, Taiwan, 200 | |
| Principal Investigator: | Yi-Hsin Tsai, M.D. | Far Eastern Memorial Hospital |
| Responsible Party: | Yi-Hsin Tsai, Chief of Neurointensive Care Unit, Far Eastern Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT03362346 |
| Other Study ID Numbers: |
106152-E |
| First Posted: | December 5, 2017 Key Record Dates |
| Last Update Posted: | June 6, 2018 |
| Last Verified: | June 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Wavelet transform Deep learning |
|
Brain Injuries Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries |

